Health Care & Life Sciences » Pharmaceuticals | Henan Taloph Pharmaceutical Stock Co. Ltd.

Henan Taloph Pharmaceutical Stock Co. Ltd. | Cash Flow

Fiscal year is January-December. All values CNY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
51,704.70
50,172.70
4,405.70
1,853.30
7,368.00
115,458.10
Depreciation, Depletion & Amortization
40,266.00
44,006.20
52,290.60
58,040.70
56,293.00
56,677.80
Other Funds
309,131.80
33,949.00
20,359.90
2,999.30
53,607.00
208,341.50
Funds from Operations
134,934.30
146,413.80
97,075.30
60,655.40
133,368.40
138,416.80
Changes in Working Capital
141,582.60
54,351.50
45,330.60
57,207.30
107,999.00
18,612.50
Net Operating Cash Flow
6,648.20
92,062.30
51,744.70
3,448.10
25,369.40
119,804.30
Capital Expenditures
22,248.80
35,623.00
62,038.00
59,605.00
44,341.40
Sale of Fixed Assets & Businesses
53.20
27.70
214.90
15,422.70
61,276.90
Purchase/Sale of Investments
-
61,000.00
40,667.70
16,100.00
100,844.00
Net Investing Cash Flow
23,037.10
96,343.70
226,314.90
29,530.40
83,908.50
Cash Dividends Paid - Total
-
12,415.20
5,738.90
-
-
Issuance/Reduction of Debt, Net
49,650.00
244,055.70
81,500.60
38,450.00
97,500.00
Net Financing Cash Flow
358,781.80
197,691.40
96,121.70
41,449.30
43,893.00
Net Change in Cash
329,096.40
193,410.00
78,448.50
15,367.10
14,646.20
Free Cash Flow
28,897.10
56,439.40
10,293.30
56,156.90
18,972.00
Deferred Taxes & Investment Tax Credit
745.20
734.30
19,611.90
250.40
8,888.80
11,144.40
Net Assets from Acquisitions
841.50
-
123,824.10
1,448.10
-
Other Sources
-
251.50
-
-
-

About Henan Taloph Pharmaceutical Stock Co.

View Profile
Address
No. 8 Jinsuo Road
Zhengzhou Henan 450001
China
Employees -
Website http://www.taloph.com
Updated 07/08/2019
Henan Taloph Pharmaceutical Stock Co., Ltd. engages in the pharmaceutical manufacturing, management, and scientific research of Chinese and western medicine products. . Its business is divided into four segments: Chinese medicine oral solution pharmaceutical preparation business, Chinese herbal oral and tablets business, pharmaceutical research and development technical services, and medical business.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.